70. Spinal stenosis Clinical trials / Disease details


Clinical trials : 96 Drugs : 203 - (DrugBank : 60) / Drug target genes : 66 - Drug target pathways : 89

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03532945
(ClinicalTrials.gov)
October 28, 20102/5/2018A Follow-up Study to Evaluate the Efficacy and Safety of Novomax in Posterior Lumbar Interbody FusionA Long-term Follow-up Study to Evaluate the Efficacy and Safety for the Patients With Bioactive Glass-ceramic Intervertebral Spacer (Novomax) in Posterior Lumbar Interbody Fusion: Comparison With a Titanium CageDegenerative Lumbar Spinal StenosisDevice: Bioactive Glass-Ceramic Spacer;Device: Titanium cageBioAlpha Inc.NULLCompleted30 Years80 YearsAll62N/ANULL